HC Wainwright Forecasts Strong Price Appreciation for DiaMedica Therapeutics (NASDAQ:DMAC) Stock
DiaMedica Therapeutics (NASDAQ:DMAC – Get Free Report) had its target price boosted by equities researchers at HC Wainwright from $7.00 to $10.00 in a report released on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price objective suggests a potential upside of 94.55% from the company’s previous close. DiaMedica […]
DiaMedica Therapeutics (NASDAQ:DMAC – Get Free Report) had its target price boosted by equities researchers at HC Wainwright from $7.00 to $10.00 in a report released on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price objective suggests a potential upside of 94.55% from the company’s previous close. DiaMedica […]
